Public concern over deep vein thrombosis has helped boost revenues of listed biotech Agenix to a record $29 million in the nine months to March 31. [ + ]

A device for the early detection of skin cancer has been launched by Sydney-based medical device company, Polartechnics. [ + ]

A consortium of eight research groups is pitching for Victorian Government support in a bid to become Australia's first fee-for-service pharmaceutical pipeline group. [ + ]

Victoria's government has unveiled a cash injection of $68.7 million for biotechnology and commercialisation, including a doubling in funding for medical research infrastructure in a bid to lure top scientists back to the state. [ + ]

With the legal closing on Friday May 3 of its Compaq acquisition, and a turbulent nine months behind it, Hewlett-Packard is at last poised to commence merged operations. [ + ]

Melbourne-based researchers are developing a transgenic rye grass that will reduce the risk of hay fever in allergy sufferers. [ + ]

Monsanto and Nufarm have given Australia's consumer watchdog court-enforceable undertakings that they will not try to stop agricultural glyphosate herbicides being imported from China. [ + ]

CEOs of Australia's leading technology companies believe that the biotechnology and internet security sectors have the greatest potential for growth in the next 12 months, according to a Deloitte industry survey. [ + ]

Peptech will reap further profits from its Remicade anti-TNF antibody in Britain. [ + ]

Former Prime Minister Bob Hawke has resigned as a director of Autogen's board, citing heavy business and personal commitments. [ + ]

The suspension of the Federal government's R&D Start program, purportedly for being too successful, flew in the face of Australia's need to compete in the global biotechnology arena, Prof Adrienne Clarke has warned. [ + ]

A study is underway in NSW and WA to examine endangered ecosystems using genetic techniques. [ + ]

The Ian Clunies Ross Memorial Foundation has called for nominations for its 2003 National Science and Technology Award. [ + ]

Drug development company BioDiem has appointed a pharmaceutical industry heavyweight to its board in the lead-up to a public listing this year. [ + ]

Some of the most-used global databases of DNA and amino acid sequences are riddled with errors and there is no quick fix in sight. [ + ]